CH
KURA icon

CVI Holdings’s Kura Oncology KURA Stock Holding History

CVI Holdings’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-60,800
Closed -$1.2M – 52
2019
Q2 		$1.2M Buy
+60,800
New +$1.01M 1.38% 14
2018
Q3 		– Sell
-76,200
Closed -$1.39M – 47
2018
Q2 		$1.39M Buy
+76,200
New +$1.29M 1.73% 14

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CVI Holdings's KURA Position: Q3 2019 in Review

CVI Holdings sold out of Kura Oncology (KURA) in Q3 2019, closing a stake of 60,800 shares — an estimated $1.2M sold.

CVI Holdings first reported a position in KURA in Q2 2018 and held it in 2 quarters. The position peaked at $1.39M in Q2 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • CVI Holdings reported no remaining Kura Oncology position as of Q3 2019 after selling out during the quarter.
  • CVI Holdings sold 60,800 Kura Oncology shares in Q3 2019, an estimated $1.2M.
  • CVI Holdings first reported a position in Kura Oncology in Q2 2018 and held it in 2 quarters.
  • CVI Holdings's Kura Oncology position peaked at $1.39M in Q2 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.